US 12139517
Modulators of chromosome 9 open reading frame 72 gene expression and uses thereof
granted A61KA61K31/7088A61K38/00
Quick answer
US patent 12139517 (Modulators of chromosome 9 open reading frame 72 gene expression and uses thereof) held by Sangamo Therapeutics, Inc. expires Mon Nov 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sangamo Therapeutics, Inc.
- Grant date
- Tue Nov 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K31/7088, A61K38/00, A61K48/00, A61K48/005